サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750819

米国の腹壁ヘルニア用メッシュ市場規模、シェア、動向分析レポート：メッシュタイプ別、適応症別、手技別、最終用途別、セグメント予測、2025-2030年

U.S. Ventral Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Mesh Type (Resorbable, Partially Absorbable), By Indication (Umbilical Hernia, Epigastric Hernia), By Procedure, By End Use, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 140 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
米国の腹壁ヘルニア用メッシュ市場規模、シェア、動向分析レポート：メッシュタイプ別、適応症別、手技別、最終用途別、セグメント予測、2025-2030年
出版日: 2025年05月14日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向：

米国の腹壁ヘルニア用メッシュ市場規模は2024年に3億5,670万米ドルと推計され、2025年から2030年にかけてCAGR 8.27％で成長すると予測されています。

ヘルニア症例の増加、メッシュ修復の技術進歩、予防ヘルスケアへのシフト、低侵襲処置への嗜好の高まり、医療インフラの成長が市場成長に影響を与える要因です。米国FDAによると、米国では年間100万件以上のヘルニア修復手術が行われています。

ヘルニア修復術は世界中で最も一般的な外科手術の一つです。ヘルニアの発生率は女性よりも男性の方が高いです。International Journal of Surgeryによると、年間約30万件の腹壁ヘルニア修復術が行われています。このうち75％は一次的腹壁ヘルニア（主に心窩部と臍部）、25％は切開ヘルニアです。さらに、切開ヘルニアは米国で正中開腹手術を受ける患者のほぼ10～30％によくみられます。ヘルニアの修復にかかる年間費用は約32億米ドルと推定されています。これは患者にとっては大きなヘルスケア課題であり、米国のヘルスケアシステムにとっては大きな財政的ハードルです。

腹壁ヘルニア用メッシュに対する有利な償還シナリオの存在は、患者が手術を選択することを促しています。政府や業界関係者は、患者に詳細な償還コードや比率を簡単に入手できるようにしています。コードはヘルニアの種類（原発性か再発性か）と手術方法（開腹か腹腔鏡か）に細かく分類されています。

腹壁ヘルニア用メッシュの技術的進歩は、患者の転帰を著しく改善し、合併症を減少させました。注目すべき技術革新のひとつは、軽量かつ複合的なメッシュの開発です。Parietex Composite Meshのようなこれらのメッシュは、吸収性素材と非吸収性素材を組み合わせることで、術後の不快感や慢性疼痛のリスクを軽減しながら強度を提供しています。これらの進歩には、Deep Blue Medical Advances, Inc.の高度メッシュ技術のようなイノベーションも含まれます。2024年、同社は臍ヘルニアや小さな欠損に合わせたTラインメッシュの小型版、Tラインミニを発売しました。さらに、Tラインヘルニア用メッシュのコーティングバージョンと生合成コンポジットバージョンも開発中です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の腹壁ヘルニア用メッシュ市場の変数、動向、範囲

  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国の腹壁ヘルニア用メッシュ市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の腹壁ヘルニア用メッシュ市場：メッシュタイプ別 推定・動向分析

  • セグメントダッシュボード
  • 米国の腹壁ヘルニア用メッシュ市場：メッシュタイプ別の変動分析
  • 米国の腹壁ヘルニア用メッシュ市場：メッシュタイプ別の展望
  • 2018年～2030年までの市場規模と予測および動向分析
  • 吸収性メッシュ
  • 部分吸収性メッシュ
  • 非吸収性メッシュ

第5章 米国の腹壁ヘルニア用メッシュ市場：適応症別 推定・動向分析

  • セグメントダッシュボード
  • 米国の腹壁ヘルニア用メッシュ市場：適応症別変動分析
  • 米国の腹壁ヘルニア用メッシュ市場：適応症別展望
  • 2018年～2030年までの市場規模と予測および動向分析
  • 臍ヘルニア
  • 上腹部ヘルニア
  • 切開ヘルニア
  • その他

第6章 米国の腹壁ヘルニア用メッシュ市場：手技別 推定・動向分析

  • セグメントダッシュボード
  • 米国の腹壁ヘルニア用メッシュ市場：手技別変動分析
  • 米国の腹壁ヘルニア用メッシュ市場：手技別展望
  • 2018年～2030年までの市場規模と予測および動向分析
  • 開腹手術
  • 腹腔鏡手術
  • ロボット手術
  • その他

第7章 米国の腹壁ヘルニア用メッシュ市場：最終用途別 推定・動向分析

  • セグメントダッシュボード
  • 米国の腹壁ヘルニア用メッシュ市場：最終用途別変動分析
  • 米国の腹壁ヘルニア用メッシュ市場：最終用途別展望
  • 2018年～2030年までの市場規模と予測および動向分析
  • 入院施設
  • 外来施設

第8章 競合情勢

  • 市場参入企業の分類
  • 企業市況分析、2024年
  • 主要企業プロファイル
    • Medtronic plc
    • Becton, Dickinson and Company
    • Ethicon Inc.（Johnson &Johnson MedTech）
    • Meril Life Sciences Pvt. Ltd.
    • Novus Scientific AB
    • B. Braun SE
    • TELA Bio, Inc.
    • BG Medical LLC
    • Integra LifeSciences Corporation
    • WL Gore &Associates, Inc.
    • Atrium Medical
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. ventral hernia mesh devices market, by mesh type, 2018 - 2030 (USD Million)
  • Table 4 U.S. ventral hernia mesh devices market, by indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. ventral hernia mesh devices market, by procedure, 2018 - 2030 (USD Million)
  • Table 6 U.S. ventral hernia mesh devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 US ventral hernia mesh devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 Market opportunity analysis (Current & future impact)
  • Fig. 10 SWOT Analysis by Factor (Political & Legal, Economic, and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 US Ventral hernia mesh devices market, mesh type outlook key takeaways (USD Million)
  • Fig. 13 US Ventral hernia mesh devices market: mesh type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 14 Resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Partially absorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Non-resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Ventral hernia mesh devices market, indication outlook key takeaways (USD Million)
  • Fig. 18 U.S. Ventral hernia mesh devices market: indication movement analysis, 2023 & 2030 (USD Million)
  • Fig. 19 Umbilical hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Epigastric hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Incisional hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Ventral hernia mesh devices market, procedure outlook key takeaways (USD Million)
  • Fig. 24 U.S. Ventral hernia mesh devices market: procedure movement analysis, 2023 & 2030 (USD Million)
  • Fig. 25 Open surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Laparoscopic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Robotic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Ventral hernia mesh devices market, end use outlook key takeaways (USD Million)
  • Fig. 30 U.S. Ventral hernia mesh devices market: end use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 31 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 List of key emerging companies/technology disruptors/innovators
目次
Product Code: GVR-4-68040-575-6

Market Size & Trends:

The U.S. ventral hernia mesh devices market size was estimated at USD 356.7 million in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030. The increasing cases of hernias, technological advancements in mesh repair, a shift towards preventive healthcare, growing preference for minimally invasive procedures, and a growing healthcare infrastructure are the factors affecting market growth. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.

Hernia repair is one of the most common surgical procedures worldwide. The incidence of hernia is higher in men than in women. According to the International Journal of Surgery, approximately 300,000 ventral hernia repairs are performed annually. Among these, 75% are primary ventral hernia repairs (mainly epigastric and umbilical) and 25% are incisional hernia repairs. Furthermore, incisional hernias are common in nearly 10-30% of patients in the U.S. who undergo midline laparotomies. The annual costs for hernia repairs are estimated at approximately USD 3.2 billion. This is viewed as a major healthcare challenge for patients and a significant financial hurdle for the U.S. healthcare system.

The presence of favorable reimbursement scenarios for hernia mesh devices is encouraging patients to opt for surgery. The government and industry players provide patients with easy access to detailed reimbursement codes and ratios. The codes are granulated into types of hernias (primary or recurrent) and surgery methods (open or laparoscopic).

Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and nonabsorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. These advancements include innovations like Deep Blue Medical Advances, Inc.'s advanced mesh technology. In 2024, the company launched a smaller version of the T-Line Mesh, known as the T-Line Mini, tailored for umbilical hernias and small defects. Moreover, the T-Line Hernia Mesh's coated and biosynthetic composite versions are developing.

U.S. Ventral Hernia Mesh Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the U.S. ventral hernia mesh devices market report based on mesh type, indication, procedure, and end use:

  • Mesh Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Resorbable Mesh
  • Partially Absorbable Mesh
  • Non-resorbable Mesh
  • Indication Outlook (Revenue, USD Million 2018 - 2030)
  • Umbilical Hernia
  • Epigastric Hernia
  • Incisional Hernia
  • Others
  • Procedure Outlook (Revenue, USD Million 2018 - 2030)
  • Open Surgery
  • Laparoscopic Surgery
  • Robotic Surgery
  • Others
  • End Use Outlook (Revenue, USD Million 2018 - 2030)
  • Inpatient Facilities
  • Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Mesh Type
    • 1.2.2. Indication
    • 1.2.3. Procedure
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Mesh Type outlook
    • 2.2.2. Indication outlook
    • 2.2.3. Procedure outlook
    • 2.2.4. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Ventral Hernia Mesh Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Global Shift Toward Preventive Healthcare
      • 3.1.1.2. Supportive Government Policies
      • 3.1.1.3. Increasing Incidence of Hernias
      • 3.1.1.4. Technological Advancements in Mesh Repair
      • 3.1.1.5. Growing Preference for Minimally Invasive Procedures
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. Complications Related to Mesh Implants
      • 3.1.2.2. High Costs of Advanced Meshes
      • 3.1.2.3. Product Recalls
  • 3.2. U.S. Ventral Hernia Mesh Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Bargaining power of suppliers
      • 3.2.1.2. Bargaining power of buyers
      • 3.2.1.3. Threat of substitutes
      • 3.2.1.4. Threat of new entrants
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental Landscape
      • 3.2.2.6. Legal Landscape

Chapter 4. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Movement Analysis
  • 4.3. U.S. Ventral Hernia Mesh Devices Market by Mesh Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Resorbable Mesh
    • 4.5.1. Resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Partially Absorbable Mesh
    • 4.6.1. Partially Absorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Non-resorbable Mesh
    • 4.7.1. Non-resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Ventral Hernia Mesh Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Ventral Hernia Mesh Devices Market: Indication Movement Analysis
  • 5.3. U.S. Ventral Hernia Mesh Devices Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Umbilical Hernia
    • 5.5.1. Umbilical Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Epigastric Hernia
    • 5.6.1. Epigastric Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Incisional Hernia
    • 5.7.1. Incisional Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Ventral Hernia Mesh Devices Market: Procedure Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Ventral Hernia Mesh Devices Market: Procedure Movement Analysis
  • 6.3. U.S. Ventral Hernia Mesh Devices Market by Procedure Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Open Surgery
    • 6.5.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Laparoscopic Surgery
    • 6.6.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Robotic Surgery
    • 6.7.1. Robotic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Ventral Hernia Mesh Devices Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Ventral Hernia Mesh Devices Market: End-use Movement Analysis
  • 7.3. U.S. Ventral Hernia Mesh Devices Market by End-use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Inpatient Facilities
    • 7.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Outpatient Facilities
    • 7.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Key Company Profiles
    • 8.3.1. Medtronic plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Becton, Dickinson and Company
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Ethicon Inc. (Johnson & Johnson MedTech)
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Meril Life Sciences Pvt. Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Novus Scientific AB
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TELA Bio, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. BG Medical LLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Integra LifeSciences Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. W. L. Gore & Associates, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Atrium Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives